Predicting and Overcoming Taxane Chemoresistance
- 1 February 2021
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 27 (2) , 138-151
Abstract
No abstract availableKeywords
Funding Information
- Fondation ARC pour la Recherche sur le Cancer
- Agence Nationale de la Recherche (MMO ANR-10-IBHU-0001)
- Institut Gustave-Roussy
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Ligue Contre le Cancer
This publication has 99 references indexed in Scilit:
- End-binding proteins sensitize microtubules to the action of microtubule-targeting agentsProceedings of the National Academy of Sciences, 2013
- Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapyJournal of Experimental & Clinical Cancer Research, 2013
- Overexpression of Mitotic Centromere–Associated Kinesin Stimulates Microtubule Detachment and Confers Resistance to PaclitaxelMolecular Cancer Therapeutics, 2011
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7Nature, 2011
- Mitosis is not a key target of microtubule agents in patient tumorsNature Reviews Clinical Oncology, 2011
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxelCancer, 2009
- Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian CarcinomasClinical Cancer Research, 2009
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic DrugsCancer Cell, 2008
- Promotion of microtubule assembly in vitro by taxolNature, 1979